Find a Location

Barbara Davis Center

Aurora, CO, United States

The Barbara Davis Center is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Peter Gottlieb, MD, the TrialNet team at the Barbara Davis Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.  

Benaroya Research Institute

Seattle, WA, United States

Benaroya Research Institute (BRI) is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Carla Greenbaum, MD, the TrialNet team at BRI is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Children's Mercy Hospital

Kansas City, MO, United States

Children's Mercy Hospital is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Wayne Moore, MD, PhD the TrialNet team at Children's Mercy is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Columbia University

New York, NY, United States

Columbia University is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Robin Goland, MD, the TrialNet team at Columbia University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Emory Children's Center

Atlanta, GA, United States

Emory Children’s Center is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Andrew Muir, MD, the TrialNet team at Emory is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

 

Lund University

Malmö, Sweden

TrialNet Sweden is one of twenty five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Åke Lernmark, the TrialNet team at TrialNet Sweden is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Riley Hospital for Children

Indianapolis, IN, United States

Riley Hospital for Children is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Principal Investigator, Linda DiMeglio, MD, the TrialNet team at the Riley's is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Sanford Health

Fargo, ND, United States

Led by Luis Casas, MD, the TrialNet team at Sanford Health is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Stanford University

Stanford, CA, United States

Stanford University is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Darrell Wilson, MD, the TrialNet team at Stanford University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.   

The Hospital for Sick Children

Toronto, ON, Canada

The Hospital for Sick Children (SickKids) is one of twenty-five type 1 diabetes TrialNet International Clinical Centres at the forefront of type 1 diabetes research. Led by Diane Wherrett, MD, the TrialNet team at SickKids is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.